This affected 17/333 pathway-associated genes including six known cancer genes (HNRNPA2B1, STAG2, TCF7L2, SUZ12, CLTC, and ZNF521), Thus, the integration procedure prioritized specific pathway-related genes compared to their original rankings in individual mutation datasets. This evidence concerns the gene SUZ12 and cancer.